Lipid Disorder Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: L900963A3DB4EN
Market Monitor Global

Abstracts

Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,.

This report contains market size and forecasts of Lipid Disorder Treatment in Global, including the following market information:

Global Lipid Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lipid Disorder Treatment market was valued at 20740 million in 2021 and is projected to reach US$ 31450 million by 2028, at a CAGR of 6.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Atorvastatin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lipid Disorder Treatment include Teva Pharmaceuticals, Mylan Pharmaceuticals, Kowa Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceuticals and Wockhardt, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lipid Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lipid Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lipid Disorder Treatment Market Segment Percentages, by Type, 2021 (%)

• Atorvastatin
• Fluvastatin
• Rosuvastatin
• Simvastatin
• Pravastatin
• Other Drugs

Global Lipid Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lipid Disorder Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Lipid Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lipid Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lipid Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lipid Disorder Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva Pharmaceuticals
• Mylan Pharmaceuticals
• Kowa Pharmaceuticals
• Glenmark Pharmaceuticals
• Sun Pharmaceuticals
• Wockhardt

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lipid Disorder Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lipid Disorder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIPID DISORDER TREATMENT OVERALL MARKET SIZE

2.1 Global Lipid Disorder Treatment Market Size: 2021 VS 2028
2.2 Global Lipid Disorder Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lipid Disorder Treatment Players in Global Market
3.2 Top Global Lipid Disorder Treatment Companies Ranked by Revenue
3.3 Global Lipid Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Lipid Disorder Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lipid Disorder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lipid Disorder Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Lipid Disorder Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lipid Disorder Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lipid Disorder Treatment Market Size Markets, 2021 & 2028
  4.1.2 Atorvastatin
  4.1.3 Fluvastatin
  4.1.4 Rosuvastatin
  4.1.5 Simvastatin
  4.1.6 Pravastatin
  4.1.7 Other Drugs
4.2 By Type - Global Lipid Disorder Treatment Revenue & Forecasts
  4.2.1 By Type - Global Lipid Disorder Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Lipid Disorder Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Lipid Disorder Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lipid Disorder Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Lipid Disorder Treatment Revenue & Forecasts
  5.2.1 By Application - Global Lipid Disorder Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Lipid Disorder Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Lipid Disorder Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lipid Disorder Treatment Market Size, 2021 & 2028
6.2 By Region - Global Lipid Disorder Treatment Revenue & Forecasts
  6.2.1 By Region - Global Lipid Disorder Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Lipid Disorder Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Lipid Disorder Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lipid Disorder Treatment Revenue, 2017-2028
  6.3.2 US Lipid Disorder Treatment Market Size, 2017-2028
  6.3.3 Canada Lipid Disorder Treatment Market Size, 2017-2028
  6.3.4 Mexico Lipid Disorder Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lipid Disorder Treatment Revenue, 2017-2028
  6.4.2 Germany Lipid Disorder Treatment Market Size, 2017-2028
  6.4.3 France Lipid Disorder Treatment Market Size, 2017-2028
  6.4.4 U.K. Lipid Disorder Treatment Market Size, 2017-2028
  6.4.5 Italy Lipid Disorder Treatment Market Size, 2017-2028
  6.4.6 Russia Lipid Disorder Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Lipid Disorder Treatment Market Size, 2017-2028
  6.4.8 Benelux Lipid Disorder Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lipid Disorder Treatment Revenue, 2017-2028
  6.5.2 China Lipid Disorder Treatment Market Size, 2017-2028
  6.5.3 Japan Lipid Disorder Treatment Market Size, 2017-2028
  6.5.4 South Korea Lipid Disorder Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Lipid Disorder Treatment Market Size, 2017-2028
  6.5.6 India Lipid Disorder Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lipid Disorder Treatment Revenue, 2017-2028
  6.6.2 Brazil Lipid Disorder Treatment Market Size, 2017-2028
  6.6.3 Argentina Lipid Disorder Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lipid Disorder Treatment Revenue, 2017-2028
  6.7.2 Turkey Lipid Disorder Treatment Market Size, 2017-2028
  6.7.3 Israel Lipid Disorder Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Lipid Disorder Treatment Market Size, 2017-2028
  6.7.5 UAE Lipid Disorder Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva Pharmaceuticals
  7.1.1 Teva Pharmaceuticals Corporate Summary
  7.1.2 Teva Pharmaceuticals Business Overview
  7.1.3 Teva Pharmaceuticals Lipid Disorder Treatment Major Product Offerings
  7.1.4 Teva Pharmaceuticals Lipid Disorder Treatment Revenue in Global Market (2017-2022)
  7.1.5 Teva Pharmaceuticals Key News
7.2 Mylan Pharmaceuticals
  7.2.1 Mylan Pharmaceuticals Corporate Summary
  7.2.2 Mylan Pharmaceuticals Business Overview
  7.2.3 Mylan Pharmaceuticals Lipid Disorder Treatment Major Product Offerings
  7.2.4 Mylan Pharmaceuticals Lipid Disorder Treatment Revenue in Global Market (2017-2022)
  7.2.5 Mylan Pharmaceuticals Key News
7.3 Kowa Pharmaceuticals
  7.3.1 Kowa Pharmaceuticals Corporate Summary
  7.3.2 Kowa Pharmaceuticals Business Overview
  7.3.3 Kowa Pharmaceuticals Lipid Disorder Treatment Major Product Offerings
  7.3.4 Kowa Pharmaceuticals Lipid Disorder Treatment Revenue in Global Market (2017-2022)
  7.3.5 Kowa Pharmaceuticals Key News
7.4 Glenmark Pharmaceuticals
  7.4.1 Glenmark Pharmaceuticals Corporate Summary
  7.4.2 Glenmark Pharmaceuticals Business Overview
  7.4.3 Glenmark Pharmaceuticals Lipid Disorder Treatment Major Product Offerings
  7.4.4 Glenmark Pharmaceuticals Lipid Disorder Treatment Revenue in Global Market (2017-2022)
  7.4.5 Glenmark Pharmaceuticals Key News
7.5 Sun Pharmaceuticals
  7.5.1 Sun Pharmaceuticals Corporate Summary
  7.5.2 Sun Pharmaceuticals Business Overview
  7.5.3 Sun Pharmaceuticals Lipid Disorder Treatment Major Product Offerings
  7.5.4 Sun Pharmaceuticals Lipid Disorder Treatment Revenue in Global Market (2017-2022)
  7.5.5 Sun Pharmaceuticals Key News
7.6 Wockhardt
  7.6.1 Wockhardt Corporate Summary
  7.6.2 Wockhardt Business Overview
  7.6.3 Wockhardt Lipid Disorder Treatment Major Product Offerings
  7.6.4 Wockhardt Lipid Disorder Treatment Revenue in Global Market (2017-2022)
  7.6.5 Wockhardt Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lipid Disorder Treatment Market Opportunities & Trends in Global Market
Table 2. Lipid Disorder Treatment Market Drivers in Global Market
Table 3. Lipid Disorder Treatment Market Restraints in Global Market
Table 4. Key Players of Lipid Disorder Treatment in Global Market
Table 5. Top Lipid Disorder Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lipid Disorder Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lipid Disorder Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lipid Disorder Treatment Product Type
Table 9. List of Global Tier 1 Lipid Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lipid Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lipid Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lipid Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lipid Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lipid Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lipid Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lipid Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lipid Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lipid Disorder Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lipid Disorder Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lipid Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lipid Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lipid Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lipid Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lipid Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Teva Pharmaceuticals Corporate Summary
Table 31. Teva Pharmaceuticals Lipid Disorder Treatment Product Offerings
Table 32. Teva Pharmaceuticals Lipid Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Mylan Pharmaceuticals Corporate Summary
Table 34. Mylan Pharmaceuticals Lipid Disorder Treatment Product Offerings
Table 35. Mylan Pharmaceuticals Lipid Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Kowa Pharmaceuticals Corporate Summary
Table 37. Kowa Pharmaceuticals Lipid Disorder Treatment Product Offerings
Table 38. Kowa Pharmaceuticals Lipid Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Glenmark Pharmaceuticals Corporate Summary
Table 40. Glenmark Pharmaceuticals Lipid Disorder Treatment Product Offerings
Table 41. Glenmark Pharmaceuticals Lipid Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Sun Pharmaceuticals Corporate Summary
Table 43. Sun Pharmaceuticals Lipid Disorder Treatment Product Offerings
Table 44. Sun Pharmaceuticals Lipid Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Wockhardt Corporate Summary
Table 46. Wockhardt Lipid Disorder Treatment Product Offerings
Table 47. Wockhardt Lipid Disorder Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lipid Disorder Treatment Segment by Type in 2021
Figure 2. Lipid Disorder Treatment Segment by Application in 2021
Figure 3. Global Lipid Disorder Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lipid Disorder Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lipid Disorder Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lipid Disorder Treatment Revenue in 2021
Figure 8. By Type - Global Lipid Disorder Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lipid Disorder Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lipid Disorder Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lipid Disorder Treatment Revenue Market Share, 2017-2028
Figure 12. US Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lipid Disorder Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lipid Disorder Treatment Revenue Market Share, 2017-2028
Figure 24. China Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lipid Disorder Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lipid Disorder Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lipid Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Pharmaceuticals Lipid Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan Pharmaceuticals Lipid Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Kowa Pharmaceuticals Lipid Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Glenmark Pharmaceuticals Lipid Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sun Pharmaceuticals Lipid Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Wockhardt Lipid Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)